Mitochondria, protein folding & geroprotectors
National University of Singapore
Levels of Longevity Map Vincenzo explores
Vincenzo Sorrentino is one of 100+ experts in the Live Beyond Project — a father & son quest for longevity.
Discover Live Beyond →Vincenzo Sorrentino is an aging biologist at the National University of Singapore, part of the city’s remarkable longevity cluster around Brian Kennedy. His science sits where the cell makes its energy and keeps its proteins in order — mitochondria, energy metabolism, and the quality control that stops proteins from misfolding as we age.
He first made his name showing that “energy boosters” — interventions that improve mitochondrial function — could reduce age-associated amyloid, the sticky protein aggregates of aging, even in the muscles of old mice. That points to a bigger idea he is chasing now: catching protein aggregation before it becomes disease, and finding compounds that help cells fold, clear and repair.
It is patient, mechanistic work, and he is refreshingly open about the path from lab to life: screen candidates in worms, validate the best in mice, and — ideally using drugs already in the FDA library — work out whether they can help humans. Much of this he does hand-in-hand with his friend and collaborator Jan Gruber, whose worm-screening platform pairs neatly with Vincenzo’s biology.
What stayed with us on the walk was his spirit about the whole endeavour. Aging, he says, is complex but fascinating — a live discovery that everyone can take part in, not just a handful of scientists. It needs biologists, engineers and ordinary people to learn about it and talk about it together.
We met Vincenzo in Singapore in 2023, in the orbit of the NUS longevity group with Brian Kennedy. Rather than a formal interview, we filmed him and Jan Gruber walking and talking as the two friends and collaborators do — trading ideas about worms, clocks, mitochondria and misfolding under the Supertrees. Marek’s own full interviews with them are still to come; this page shares that conversation.
“It brings this discovery feeling that there’s something new we can do — and everyone can participate.”
— Vincenzo Sorrentino, Singapore
“Aging is very complex, but it’s actually fascinating — it brings this discovery feeling that there’s something new we can do, and everyone can participate.”
Vincenzo Sorrentino · Vincenzo Sorrentino · SingaporeAging is very complex, but it’s actually fascinating — and everyone can participate, not just a few scientists.
Vincenzo SorrentinoOne approach I’m interested in is understanding why misfolding happens in the first place — before disease occurs.
Vincenzo SorrentinoEnergy boosters reduced age-associated amyloid even in the muscles of aged mice.
Vincenzo SorrentinoIf the best drugs are already FDA-library drugs, we can try to figure out whether they’re usable in humans.
Vincenzo SorrentinoThree threads Vincenzo keeps pulling on.
Mitochondria are where the cell makes its energy, and their decline runs through much of aging. Vincenzo’s work on energy metabolism — the biology behind boosters like NAD precursors and urolithin A — asks how keeping mitochondria healthy protects tissues as we grow old.
“Keep the cell’s power on.”
Singapore · from the interviewMisfolded proteins clump into aggregates with age. His aim is to understand why that happens in the first place — before it becomes disease — and to find compounds that help cells fold, degrade and clear those aggregates, restoring proteostasis.
“Target the aggregates before disease occurs.”
Singapore · from the interviewA clear translational path: screen candidates in C. elegans, validate the strongest in aged mice where amyloid is present, and prefer drugs already in FDA libraries so the road to people is shorter. Done with Jan Gruber’s screening platform.
“Screen in worms, validate in mice, aim for humans.”
Singapore · from the interviewVincenzo Sorrentino is an aging biologist at the National University of Singapore. This page shares his walk-and-talk with Jan Gruber on the Live Beyond quest; the full interview is still to come.
The video interview is coming. Recorded interviews go live after the launch of the film & series Live Beyond.
Filmed in Singapore, 2023 — a walk-and-talk between Vincenzo Sorrentino and his collaborator Jan Gruber. Passages:
Vincenzo Sorrentino“They’ll come out of this with the idea that aging is very complex, but actually fascinating. It almost brings this discovery feeling — that there’s something new we can do, and everyone can participate. It’s not just for a few scientists to figure out; you need biologists, engineers and laypeople to learn about it, and to communicate it.”
Vincenzo Sorrentino“One of the approaches I’m interested in is to understand why there is this misfolding in the first place. If we could find out how protein aggregates form in aging — independent of disease, before disease occurs — then maybe we can target them differently, with new compounds. In my earlier work, energy boosters reduced age-associated amyloid even in the muscles of aged mice.”
Vincenzo Sorrentino“We’d select the best drug candidates, provide them to aged mice where we know there’s age-associated amyloid, and look at whether we’re promoting the clearance or folding of those aggregates. And if these drugs are already FDA-library drugs, used for some other application, we can then try to figure out whether they’re usable in humans.”
Jan Gruber“Reducing the noise would be a cool first screen — then we confirm the lifespan and healthspan down the line, and maybe try it in flies and mice.”
Vincenzo Sorrentino“Exactly — you start from the screen on large numbers, then validate more mechanistically. It’s a way to directly link new interventions to different aspects of aging that we still haven’t screened enough for.”
More passages from the full interview will be published here.
Vincenzo Sorrentino sits in Biohacking Upgrades on the Longevity Map — the biology of energy, folding and geroprotectors. Explore the rest of the cast on the People page.
Explore all 100+ expertsAlso on the Hub
Places this page mentions, each with a page of its own.